Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers

NCT01434680 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

992

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Disease
Meningococcal Meningitis

Interventions

BIOLOGICAL: MenC-CRM LIQ
BIOLOGICAL: MenC-CRM ROS
BIOLOGICAL: MenC-CRM EMV

Sponsor

Novartis

Collaborators

[object Object]